{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T16:23:41Z","timestamp":1793723021738,"version":"4.6.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,13]],"date-time":"2018-06-13T00:00:00Z","timestamp":1528848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,6,13]],"date-time":"2018-06-13T00:00:00Z","timestamp":1528848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Leptomeningeal metastases (LM) are a serious complication of cancer in the central nervous system (CNS) and are diagnosed in approximately 5% of patients with solid tumors. Effective treatment using systemically administered therapeutics is hindered by the barriers of the CNS. Ultrasound can mediate delivery of drugs through these barriers. The goal of this study was to test the feasibility of using ultrasound-mediated drug delivery to improve the treatment of LM. LM was induced in the spinal cord of athymic rats by injecting HER2-expressing breast cancer cells into the subarachnoid space of the thoracic spine. Animals were divided into three groups: no treatment (n\u2009=\u20095), trastuzumab only (n\u2009=\u20096) or trastuzumab\u2009+\u2009focused ultrasound\u2009+\u2009microbubbles (FUS\u2009+\u2009MBs) (n\u2009=\u20097). Animals in groups 2 and 3 were treated weekly with intravenous trastuzumab\u2009+\/\u2212\u2009FUS\u2009+\u2009MBs for three weeks. Suppression in tumor growth was qualitatively observed by MRI in the group receiving ultrasound, and was confirmed by a significant difference in the tumor volume measured from the histology data (25\u2009\u00b1\u200917\u2009mm<jats:sup>3<\/jats:sup> vs 8\u2009\u00b1\u20095\u2009mm<jats:sup>3<\/jats:sup>, p\u2009=\u20090.04 in the trastuzumab-only vs trastuzumab\u2009+\u2009FUS\u2009+\u2009MBs). This pilot study demonstrates the potential of ultrasound-mediated drug delivery as a novel treatment for LM. Future studies will extend this work to larger cohorts and the investigation of LM arising from other cancers.<\/jats:p>","DOI":"10.1038\/s41598-018-27335-y","type":"journal-article","created":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T09:33:07Z","timestamp":1528363987000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Preliminary Investigation of Focused Ultrasound-Facilitated Drug Delivery for the Treatment of Leptomeningeal Metastases"],"prefix":"10.1038","volume":"8","author":[{"given":"Meaghan A.","family":"O\u2019Reilly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tricia","family":"Chinnery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"My-Linh","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Kai","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kullervo","family":"Hynynen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Kerbel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Czarnota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen I.","family":"Pritchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjun","family":"Sahgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,13]]},"reference":[{"issue":"6","key":"27335_CR1","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1097\/WCO.0b013e3283322a92","volume":"22","author":"MC Chamberlain","year":"2009","unstructured":"Chamberlain, M. C. Leptomeningeal metastasis. Curr Opin Neurol 22(6), 665\u2013674 (2009).","journal-title":"Curr Opin Neurol"},{"issue":"3","key":"27335_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/jso.2930230311","volume":"23","author":"YT Lee","year":"1983","unstructured":"Lee, Y. T. Breast carcinoma: pattern of metastasis at autopsy. J Surg Oncol 23(3), 175\u2013180 (1983).","journal-title":"J Surg Oncol"},{"issue":"1","key":"27335_CR3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11060-004-8101-x","volume":"75","author":"S Taillibert","year":"2005","unstructured":"Taillibert, S. et al. Leptomeningeal metastases from solid malignancy: a review. J Neurooncol 75(1), 85\u201399 (2005).","journal-title":"J Neurooncol"},{"issue":"11","key":"27335_CR4","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1093\/annonc\/mdq232","volume":"21","author":"H Gauthier","year":"2010","unstructured":"Gauthier, H. et al. Survival of breast cancer patients with meningeal carcinomatosis. Ann Oncol 21(11), 2183\u20132187 (2010).","journal-title":"Ann Oncol"},{"issue":"Suppl 4","key":"27335_CR5","first-page":"S265","volume":"4","author":"E Le Rhun","year":"2013","unstructured":"Le Rhun, E., Taillibert, S. & Chamberlain, M. C. Carcinomatous meningitis: Leptomeningeal metastases in solid tumors. Surg Neurol Int 4(Suppl 4), S265\u2013S288 (2013).","journal-title":"Surg Neurol Int"},{"issue":"2","key":"27335_CR6","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/CMR.0b013e32835e589c","volume":"23","author":"JM Lee","year":"2013","unstructured":"Lee, J. M. et al. Long-term stabilization of leptomeningeal disease with whole-brain radiation therapy in a patient with metastatic melanoma treated with vemurafenib: a case report. Melanoma Res 23(2), 175\u2013178 (2013).","journal-title":"Melanoma Res"},{"issue":"1","key":"27335_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","volume":"2","author":"WM Pardridge","year":"2005","unstructured":"Pardridge, W. M. The blood-brain barrier: bottleneck in brain drug development. NeuroRx 2(1), 3\u201314 (2005).","journal-title":"NeuroRx"},{"issue":"4","key":"27335_CR8","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7","volume":"49","author":"WR Wasserstrom","year":"1982","unstructured":"Wasserstrom, W. R., Glass, J. P. & Posner, J. B. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 49(4), 759\u2013772 (1982).","journal-title":"Cancer"},{"key":"27335_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s40425-015-0084-y","volume":"3","author":"NT Lu","year":"2015","unstructured":"Lu, N. T. et al. Intrathecal trastuzumab: immunotherapy improves the prognosis of leptomeningeal metastases in her-2+ breast cancer patient. J Immunother Cancer 3, 41 (2015).","journal-title":"J Immunother Cancer"},{"issue":"3","key":"27335_CR10","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1148\/radiol.2202001804","volume":"220","author":"K Hynynen","year":"2001","unstructured":"Hynynen, K., McDannold, N., Vykhodtseva, N. & Jolesz, F. A. Noninvasive mr imaging-guided focal opening of the blood-brain barrier in rabbits. Radiology 220(3), 640\u2013646 (2001).","journal-title":"Radiology"},{"issue":"2","key":"27335_CR11","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1148\/radiol.10090699","volume":"255","author":"H-L Liu","year":"2010","unstructured":"Liu, H.-L. et al. Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment. Radiology 255(2), 415\u2013425 (2010).","journal-title":"Radiology"},{"issue":"4","key":"27335_CR12","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1002\/ijc.22732","volume":"121","author":"L Treat","year":"2007","unstructured":"Treat, L. et al. Targeted delivery of doxorubicin to the rat brain at therapeutic levels using mri-guided focused ultrasound. Int. J. Cancer 121(4), 901\u2013907 (2007).","journal-title":"Int. J. Cancer"},{"issue":"1-2","key":"27335_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.jconrel.2013.04.007","volume":"169","author":"M Aryal","year":"2013","unstructured":"Aryal, M., Vykhodtseva, N., Zhang, Y.-Z., Park, J. & McDannold, N. Multiple treatments with liposomal doxorubicin and ultrasound-induced disruption of blood-tumor and blood-brain barriers improve outcomes in a rat glioma model. J Control Release 169(1-2), 103\u2013111 (2013).","journal-title":"J Control Release"},{"issue":"5","key":"27335_CR14","doi-asserted-by":"publisher","first-page":"e10549","DOI":"10.1371\/journal.pone.0010549","volume":"5","author":"J Jord\u00e3o","year":"2010","unstructured":"Jord\u00e3o, J. et al. Antibodies targeted to the brain with image-guided focused ultrasound reduces amyloid-beta plaque load in the tgcrnd8 mouse model of alzheimer\u2019s disease. PLoS ONE 5(5), e10549 (2010).","journal-title":"PLoS ONE"},{"issue":"31","key":"27335_CR15","doi-asserted-by":"publisher","first-page":"11719","DOI":"10.1073\/pnas.0604318103","volume":"103","author":"M Kinoshita","year":"2006","unstructured":"Kinoshita, M., McDannold, N., Jolesz, F. & Hynynen, K. Noninvasive localized delivery of herceptin to the mouse brain by mri-guided focused ultrasound-induced blood-brain barrier disruption. Proc. Natl. Acad. Sci. USA 103(31), 11719\u201311723 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"27335_CR16","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1089\/hum.2012.013","volume":"23","author":"E Th\u00e9venot","year":"2012","unstructured":"Th\u00e9venot, E. et al. Targeted delivery of self-complementary adeno-associated virus serotype 9 to the brain, using magnetic resonance imaging-guided focused ultrasound. Hum Gene Ther 23(11), 1144\u20131155 (2012).","journal-title":"Hum Gene Ther"},{"issue":"1","key":"27335_CR17","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/gt.2014.91","volume":"22","author":"S Wang","year":"2015","unstructured":"Wang, S., Olumolade, O. O., Sun, T., Samiotaki, G. & Konofagou, E. E. Noninvasive, neuron-specific gene therapy can be facilitated by focused ultrasound and recombinant adeno-associated virus. Gene Ther 22(1), 104\u2013110 (2015).","journal-title":"Gene Ther"},{"issue":"11","key":"27335_CR18","doi-asserted-by":"publisher","first-page":"e27877","DOI":"10.1371\/journal.pone.0027877","volume":"6","author":"A Burgess","year":"2011","unstructured":"Burgess, A. et al. Targeted delivery of neural stem cells to the brain using mri-guided focused ultrasound to disrupt the blood-brain barrier. PLoS One 6(11), e27877 (2011).","journal-title":"PLoS One"},{"key":"27335_CR19","doi-asserted-by":"crossref","unstructured":"Weber-Adrian, D., et al. Gene delivery to the spinal cord using mri-guided focused ultrasound. Gene Ther (2015).","DOI":"10.1038\/gt.2015.25"},{"issue":"12","key":"27335_CR20","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.4103\/1673-5374.221162","volume":"12","author":"AH Payne","year":"2017","unstructured":"Payne, A. H. et al. Magnetic resonance imaging-guided focused ultrasound to increase localized blood-spinal cord barrier permeability. Neural regeneration research 12(12), 2045 (2017).","journal-title":"Neural regeneration research"},{"key":"27335_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-10-221","volume":"10","author":"H-L Liu","year":"2012","unstructured":"Liu, H.-L. et al. Low-pressure pulsed focused ultrasound with microbubbles promotes an anticancer immunological response. J Transl Med 10, 221 (2012).","journal-title":"J Transl Med"},{"issue":"3","key":"27335_CR22","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.jconrel.2012.09.007","volume":"163","author":"E-J Park","year":"2012","unstructured":"Park, E.-J., Zhang, Y.-Z., Vykhodtseva, N. & McDannold, N. Ultrasound-mediated blood-brain\/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model. J Control Release 163(3), 277\u2013284 (2012).","journal-title":"J Control Release"},{"issue":"3","key":"27335_CR23","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/BF02341153","volume":"9","author":"JG Kaplan","year":"1990","unstructured":"Kaplan, J. G. et al. Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias. J Neurooncol 9(3), 225\u2013229 (1990).","journal-title":"J Neurooncol"},{"issue":"2","key":"27335_CR24","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0301-5629(97)00269-X","volume":"24","author":"K Hynynen","year":"1998","unstructured":"Hynynen, K. & Jolesz, F. A. Demonstration of potential noninvasive ultrasound brain therapy through an intact skull. Ultrasound Med Biol 24(2), 275\u2013283 (1998).","journal-title":"Ultrasound Med Biol"},{"issue":"8","key":"27335_CR25","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1088\/0031-9155\/47\/8\/301","volume":"47","author":"GT Clement","year":"2002","unstructured":"Clement, G. T. & Hynynen, K. A non-invasive method for focusing ultrasound through the human skull. Phys Med Biol 47(8), 1219\u20131236 (2002).","journal-title":"Phys Med Biol"},{"issue":"11","key":"27335_CR26","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1088\/0031-9155\/53\/11\/012","volume":"53","author":"J-F Aubry","year":"2008","unstructured":"Aubry, J.-F., Pernot, M., Marquet, F., Tanter, M. & Fink, M. Transcostal high-intensity-focused ultrasound: ex vivo adaptive focusing feasibility study. Phys Med Biol 53(11), 2937\u20132951 (2008).","journal-title":"Phys Med Biol"},{"issue":"3","key":"27335_CR27","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1158\/1078-0432.CCR-05-1109","volume":"12","author":"JM du Manoir","year":"2006","unstructured":"du Manoir, J. M. et al. Strategies for delaying or treating in vivo acquired resistance to trastuzumab in human breast cancer xenografts. Clinical Cancer Research 12(3), 904\u2013916 (2006).","journal-title":"Clinical Cancer Research"},{"issue":"1","key":"27335_CR28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0165-0270(98)00115-0","volume":"85","author":"KH Janczewski","year":"1998","unstructured":"Janczewski, K. H. et al. A simple, reproducible technique for establishing leptomeningeal tumors in nude rats. J Neurosci Methods 85(1), 45\u201349 (1998).","journal-title":"J Neurosci Methods"},{"issue":"18","key":"27335_CR29","doi-asserted-by":"publisher","first-page":"5251","DOI":"10.1088\/0031-9155\/55\/18\/001","volume":"55","author":"MA O\u2019Reilly","year":"2010","unstructured":"O\u2019Reilly, M. A., Huang, Y. & Hynynen, K. The impact of standing wave effects on transcranial focused ultrasound disruption of the blood-brain barrier in a rat model. Phys Med Biol 55(18), 5251\u20135267 (2010).","journal-title":"Phys Med Biol"},{"issue":"1","key":"27335_CR30","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1148\/radiol.11111417","volume":"263","author":"MA O\u2019Reilly","year":"2012","unstructured":"O\u2019Reilly, M. A. & Hynynen, K. Blood-brain barrier: real-time feedback-controlled focused ultrasound disruption by using an acoustic emissions-based controller. Radiology 263(1), 96\u2013106 (2012).","journal-title":"Radiology"},{"issue":"1","key":"27335_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/neu.1995.12.1","volume":"12","author":"DM Basso","year":"1995","unstructured":"Basso, D. M., Beattie, M. S. & Bresnahan, J. C. A sensitive and reliable locomotor rating scale for open field testing in rats. J Neurotrauma 12(1), 1\u201321 (1995).","journal-title":"J Neurotrauma"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-27335-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-27335-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-27335-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T06:28:05Z","timestamp":1671604085000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-27335-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,13]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["27335"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-27335-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,13]]},"assertion":[{"value":"5 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.A. O\u2019Reilly and K. Hynynen are listed as co-inventors on a patent application related to the ultrasound methods used in this study. M.A. O\u2019Reilly, G.J. Czarnota and K. Hynynen have commercial research grants with FUS Instruments. K. Hynynen has ownership interest (including patents) in Sunnybrook Research Institute and Brigham and Women\u2019s Hospital, and FUS Instruments, and is a member of the FUS Instruments Board of Directors. The other authors have no conflicts to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"9013"}}